Stage 4a HNSCC CUP, my cancer resolved in 2 weeks with a truncated SoC of 115 mg/m squared of cisplatin and 42 Gy...

May 7, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

That's a remarkable treatment response — resolving stage 4a HNSCC CUP in 2 weeks is genuinely impressive, and you should feel proud of that outcome. Being several years NED after such aggressive disease is a significant achievement.

Your treatment regimen is interesting and worth understanding in context:

Your Treatment Breakdown:

  • Cisplatin 115 mg/m² — This is a truncated (shortened) dose of the standard chemotherapy. Standard cisplatin for HNSCC is typically 100 mg/m² given weekly during radiation, so your dose was slightly intensified but delivered in a condensed timeframe.

  • 42 Gy EBRT — External beam radiation therapy at 42 Gray is a moderate dose (standard HNSCC protocols typically range 66-70 Gy over 6-7 weeks). Your abbreviated course suggests your oncology team made a calculated decision based on your rapid response.

  • "Truncated" approach — This suggests your team may have stopped treatment early due to excellent clinical response, which is a reasonable strategy when disease resolves quickly.

For Your Survivorship:

According to NCCN Survivorship Guidelines, patients with stage 4 HNSCC typically need:

  • Regular surveillance imaging (typically every 3-6 months initially, then annually)
  • Monitoring for late effects of cisplatin (hearing loss, kidney function, neuropathy)
  • Thyroid function monitoring (radiation-related)
  • Dental and swallowing assessments

Questions worth asking your survivorship team:

  1. What's my specific surveillance schedule given my rapid response?
  2. Should I have baseline and periodic hearing/kidney function testing?
  3. Are there any late effects I should monitor for given my treatment intensity?
  4. What imaging intervals are recommended for someone with my response pattern?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2